News

Published on 27 Jan 2023 on Guru Focus

Eaton Vance Worldwide Health S - GuruFocus.com


Article preview image

GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Health care-focused fund reveals 4th-quarter trades

NYSE.VGT price evolution
NYSE.NVS price evolution
NYSE.HUM price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta,...

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta,...

Investing.com 21 Apr 2024

Tech advances are catalyzing the Health Care sector with improved investor sentiment -SSGA

The healthcare sector (XLV) has seen “the fruits of its labor” in higher earnings growth and help...

Seeking Alpha 19 Apr 2024

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies

FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therap...

Benzinga via Yahoo Finance 19 Apr 2024

FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)

The FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk ...

Seeking Alpha 19 Apr 2024

9 Best Biotech ETFs for 2024

Biotechnology uses living organisms to develop new medicines and technologies that benefit both e...

GoBankingRates via AOL 19 Apr 2024

Novartis (NVS) to Report Q1 Earnings: What to Expect?

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 2...

Zacks via Yahoo Finance 19 Apr 2024

CVS favors Humira copycats hurting AbbVie’s market (NYSE:CVS)

CVS Health's (CVS)decision to drop coverage for Humira and favor its cheaper biosimilars is hurti...

Seeking Alpha 17 Apr 2024

Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug

Novartis NVS presented encouraging results from a pre-specified interim analysis of the phase III...

Zacks via Yahoo Finance 16 Apr 2024

Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly...

There's a common problem with passive income: Generating it isn't as passive as investors expect....

Motley Fool via Yahoo Finance 14 Apr 2024

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...

Zacks via Yahoo Finance 12 Apr 2024